Diabetes insipidus from neurosarcoidosis: Long-term follow-up for more than eight years

Internal Medicine

Volumn 43, Issue 10, 2004, Pages 960-966

  Tabuena, Rollin P ^c   Nagai, Sonoko ^c   Handa, Tomohiro ^c   Shigematsu, Michio ^c   Hamada, Kunio ^c   Ito, Isao ^c   Izumi, Takateru ^a   Mishima, Michiaki ^c   Sharma, Om P ^b  

^a Central Clinic in Kyoto   (Japan)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Corticosteroid desmopressin; Diabetes insipidus; Hypothalamic hypophyseal syndrome; MRI; Sarcoidosis

Indexed keywords

CHORIONIC GONADOTROPIN; CORTICOSTEROID; CORTICOTROPIN; DESMOPRESSIN; ESTRADIOL; FOLLITROPIN; GADOLINIUM; GROWTH HORMONE; HYDROCORTISONE; LUTEINIZING HORMONE; PREDNISOLONE; PROLACTIN; TESTOSTERONE; THYROID HORMONE; THYROTROPIN;

ADULT; AMENORRHEA; ARTICLE; BODY WEIGHT DISORDER; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIABETES INSIPIDUS; DIABETES MELLITUS; DISEASE DURATION; DISEASE EXACERBATION; DOSE RESPONSE; DYSARTHRIA; FACIAL NERVE PARALYSIS; FAMILY HISTORY; FEMALE; FEMUR HEAD NECROSIS; FEVER; FOLLOW UP; HEMIANOPIA; HOSPITAL ADMISSION; HUMAN; HYPERPROLACTINEMIA; HYPERTENSION; HYPOGONADISM; HYPOPHYSIS DISEASE; HYPOPITUITARISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHALAMUS TUMOR; INFUNDIBULUM; LONGITUDINAL STUDY; LYMPHADENOPATHY; MALE; MEDIASTINUM LYMPH NODE; NEUROHYPOPHYSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYURIA; SARCOIDOSIS; SEX DIFFERENCE; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TREATMENT FAILURE; TUMOR VOLUME;

ADRENAL CORTEX HORMONES; ADULT; BRAIN DISEASES; DEAMINO ARGININE VASOPRESSIN; DIABETES INSIPIDUS; FEMALE; HEMOSTATICS; HUMANS; HYPERPROLACTINEMIA; HYPOGONADISM; HYPOTHALAMIC DISEASES; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY GLAND; PROGNOSIS; SARCOIDOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 8844249327     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.960     Document Type: Article

References (19)

1. Statement on Sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160: 736-755, 1999.
2. Kerdel FA, Moschella SL. Sarcoidosis. An updated review. J Am Acad Dermatol 11: 1-19, 1984.
3. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Jeager H Jr. and the ACCESS Research Group. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoidosis Vasc Diffuse Lung Dis 16 75-86, 1999.
4. Oksanen VE. Neurosarcoidosis. in: DG James, ed. Sarcoidosis and Other Granulomatous Disorders. Marcel Dekker, New York, 73: 285-309, 1994.
5. Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine 69: 261-276, 1990.
6. Ferriby D, de Seze J, Stojkovic T, et al. Long-term follow-up of neurosarcoidosis. Neurology 57: 927-929, 2001.
7. Sharma OP. Neurosarcoidosis: A personal perspective based on the study of 37 patients. Chest 112: 220-228, 1997.
8. Sakuta M. Neurosarcoidosis. Nippon Rinsho 52: 1590-1594, 1994 (in Japanese, Abstract in English).
9. Limper AH, Colby TV, Sanders MS, et al. Immunohistological localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med 149: 197-204, 1994.
10. Conner P, Freid G. Hyperprolactinemia; etiology, diagnosis and treatment alternatives. Acta Obstet Gynecol Scand 77: 249-262, 1998.
11. Bullmann C, Faust M, Hoffmann A, et al. Five cases with central diabetes insipidus and hypogonadism at first presentation of neurosarcoidosis. Eur Journal of Endocrinology 142: 365-372, 2000.
12. Pickuth D, Spielmann RP, Heywang-Kobrunner SH. Role of radiology in the diagnosis of neurosarcoidosis. Ent Radiol 10: 941-944, 2000.
13. Dumas JL, Valeyre D, Chapelon-Abric C, et al. Central nervous system sarcoidosis: Follow-up at MR imaging during steroid therapy. Radiology 214: 411-420, 2000.
14. Moore FG, Andemann F, Richardson J, et al. The role of MRI and nerve root biopsy in the diagnosis of neurosarcoidosis. Can J Neurol Sci 28: 349-353, 2001.
15. du Bois RM. Corticosteroids in sarcoidosis: friend or foe? Eur Respir J 7: 1203-1209, 1994.
16. Espinosa GA, Michael A, Wilbur A, et al. Spinal cord sarcoidosis. Mil Med 6: 309-313, 1985.
17. Luke RA, Stern BJ, Krumholz A, et al. Neurosarcoidosis: The long-term clinical course. Neurology 37: 461-463, 1987.
18. Agbogu B, Stern BJ, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 52: 875-879, 1995.
19. Vinas FC, Rengachary S. Diagnosis and management of neurosarcoidosis. Clini Neurosci 8: 505-513, 2001.